Cancer-associated venous thromboembolism and its impact on survival in the ONCOTHROMB12-01 cohort study

Cancer patients are at increased risk of venous thromboembolism (VTE), representing one of the main causes of death. In this paper, we used the ONCOTHROMB12-01 study cohort for the analysis of 18-month overall survival (OS) and cancer-associated venous thrombosis (CAT) cumulative incidence. The OS is described for patients with and without CAT across age, sex, cancer type, stage and presence of recurrent VTE using the Kaplan-Meier method and log-rank test. Moreover, a Cox regression model with stepwise feature selection is trained to identify predictors of prognosis. Results show an 18-month CAT cumulative incidence of 16.5 % (CI 13.1-21.0 %) and a median OS for patients with CAT of 9.1 months (CI 5.9-12.5). Furthermore, CAT is associated with shorter survival in lung, colorectal and pancreatic cancer in advanced stages, regardless of age and sex; VTE recurrence also reduces survival significantly. The model found ECOG performance status of 2, cancer type, metastatic stage, VTE, mucinous histology and complete tumor resection as meaningful predictors; the latter being the only protective factor. In conclusion, the diagnosis of CAT has a profound impact on OS in the ONCOTHROMB12-01 study regardless of the clinical characteristics of patients.

Authors

Institutions

Publication Details

Journal
IJC Heart & Vasculature
Published
2025-07-19
DOI
https://doi.org/10.1016/j.ijcha.2025.101754
Citations
1
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
1.87
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cancer-associated venous thromboembolism and its impact on survival in the ONCOTHROMB12-01 cohort study

Ana Rupérez, E. Martínez, Oriol Pujol, Laura Ortega et al.
1 citations
IJC Heart & Vasculature
Venous Thromboembolism Diagnosis and Management
1.87
article

Cancer-associated venous thromboembolism and its impact on survival in the ONCOTHROMB12-01 cohort study

Ana Rupérez, E. Martínez, Oriol Pujol, Laura Ortega, Bárbara Lobato-Delgado, José Manuel Soria, Virginia Martínez-Marín, Mercedes Salgado Fernández, Vanessa Pachón, Victoria Castellón, Carme Font, Julia Calzas, Magdalena Ruiz, Andrés Muñoz
article en
1 citations

Abstract

Cancer patients are at increased risk of venous thromboembolism (VTE), representing one of the main causes of death. In this paper, we used the ONCOTHROMB12-01 study cohort for the analysis of 18-month overall survival (OS) and cancer-associated venous thrombosis (CAT) cumulative incidence. The OS is described for patients with and without CAT across age, sex, cancer type, stage and presence of recurrent VTE using the Kaplan-Meier method and log-rank test. Moreover, a Cox regression model with stepwise feature selection is trained to identify predictors of prognosis. Results show an 18-month CAT cumulative incidence of 16.5 % (CI 13.1-21.0 %) and a median OS for patients with CAT of 9.1 months (CI 5.9-12.5). Furthermore, CAT is associated with shorter survival in lung, colorectal and pancreatic cancer in advanced stages, regardless of age and sex; VTE recurrence also reduces survival significantly. The model found ECOG performance status of 2, cancer type, metastatic stage, VTE, mucinous histology and complete tumor resection as meaningful predictors; the latter being the only protective factor. In conclusion, the diagnosis of CAT has a profound impact on OS in the ONCOTHROMB12-01 study regardless of the clinical characteristics of patients.

IJC Heart & VasculatureVol. 60
Hospital Universitario La Paz (ES), Instituto de Salud Carlos III (ES), Hospital de Sant Pau (ES), Hospital General Universitario Gregorio Marañón (ES), Centre for Biomedical Network Research on Rare Diseases (ES), Instituto de Investigación Marqués de Valdecilla (ES), Hospital Clínic de Barcelona (ES), Spanish Society of Hematology and Hemotherapy (ES), Hospital Universitario de Fuenlabrada (ES), Complejo Hospitalario Torrecárdenas (ES), Hospital Universitario Ramón y Cajal (ES), Complejo Hospitalario Universitario de Toledo (ES), Complejo Hospitalario de Ourense (ES), Universitat de Barcelona (ES)
Openalex Percentile: Top 12%
Venous Thromboembolism Diagnosis and Management
1.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.